Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down‐regulation of microRNA‐31

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2018-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.26716PMID 29377269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery

  2016cited by this paper
• Book Review: Principles and Practice of Pediatric Neurosurgery

  2016cited by this paper
• MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2

  2014cited by this paper
• Principles and Practice of Pediatric Neurosurgery 3rd Ed.

  2014cited by this paper
• Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.

  2013cited by this paper
• Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.

  2013cited by this paper
• Medulloblastoma

  2012cited by this paper
• The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children.

  2012cited by this paper
• Medulloblastomics: the end of the beginning

  2012cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.

  2011cited by this paper
• Development and cancer of the cerebellum.

  2011cited by this paper
• miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells*

  2010cited by this paper
• miR-31: a master regulator of metastasis?

  2010cited by this paper
• Childhood Medulloblastoma

  2010cited by this paper
• A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

  2009cited by this paper
• Proximal events in Wnt signal transduction

  2009cited by this paper
• Ginsenoside Rh2-mediated G1 Phase Cell Cycle Arrest in Human Breast Cancer Cells Is Caused by p15Ink4B and p27Kip1-dependent Inhibition of Cyclin-dependent Kinases

  2009cited by this paper
• The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.

  2009cited by this paper
• Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo‐controlled human intervention trial

  2008cited by this paper
• Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis Induction

  2008cited by this paper
• Potential role of ginseng in the treatment of colorectal cancer.

  2008cited by this paper
• Signaling pathways in medulloblastoma

  2008cited by this paper
• Sanguinarine-Induced Apoptosis in Human Leukemia U937 Cells via Bcl-2 Downregulation and Caspase-3 Activation

  2008cited by this paper
• Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma

  2008cited by this paper
• Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides

  2007cited by this paper
• Circulating MMP2 and MMP9 in breast cancer—Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories

  2006cited by this paper
• Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.

  2006cited by this paper
• Wnt signalling in stem cells and cancer

  2005cited by this paper
• Minireview: Cyclin D1: normal and abnormal functions.

  2004cited by this paper
• Molecular processes of chromosome 9p21 deletions in human cancers

  2003cited by this paper
• Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patients

  2003cited by this paper
• [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis].

  2003cited by this paper
• Control of beta-catenin signaling in tumor development.

  2000cited by this paper
• Control of β‐Catenin Signaling in Tumor Development

  2000cited by this paper
• Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.

  1999cited by this paper
• Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells

  1998cited by this paper
• Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.

  1998cited by this paper
• p21—Negative Regulator of the Cell Cycle

  1996cited by this paper

• MicroRNAs in the anti-cancer effects of Ginsenosides: A Systematic Review

  2025influential citation
• Ginsenoside Rh2 attenuates the progression of non‐small cell lung cancer by sponging miR‐28‐5p/STK4 axis and inactivating Wnt/β‐catenin signaling

  2023cites this paper
• Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics

  2022cites this paper
• The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo.

  2022cites this paper
• Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development

  2022cites this paper
• Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng

  2021cites this paper
• Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review

  2021cites this paper
• The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors

  2021cites this paper
• Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation

  2021cites this paper
• A recent overview on ginsenosides as microRNA modulators in the treatment of human diseases

  2021cites this paper
• CN‐3 increases TMZ sensitivity and induces ROS‐dependent apoptosis and autophagy in TMZ‐resistance glioblastoma

  2021cites this paper
• Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells.

  2020cites this paper
• Geniposide exhibits anticancer activity to medulloblastoma cells by downregulating microRNA‐373

  2020cites this paper
• MicroRNAs mediate the anti-tumor and protective effects of ginsenosides

  2020cites this paper
• Roles of plant‐derived bioactive compounds and related microRNAs in cancer therapy

  2020cites this paper
• Anticancer property of ginsenoside Rh2 from ginseng.

  2020cites this paper
• Increased antitumor efficacy of ginsenoside Rh2 via mixed micelles: in vivo and in vitro evaluation

  2020cites this paper
• Pharmacokinetics of Ginsenoside Rh2, the Major Anticancer Ingredient of Ginsenoside H Dripping Pills, in Healthy Subjects

  2020cites this paper
• Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells Under Hypoxia via mir-491.

  2019cites this paper
• NF-κB-regulation of miR-155, via SOCS1/STAT3, is involved in the PM2.5-accelerated cell cycle and proliferation of human bronchial epithelial cells.

  2019cites this paper